Antidepressants Guide: Why Staying With Treatment Matters as Much as the Pill You Pick
Clinically reviewed by Daniel Montville, MD
Reviewed November 5, 2026 · Last updated November 5, 2026
Key Takeaways
- Antidepressants usually take 4 to 8 weeks to work, and sleep, appetite, energy, and concentration often improve before mood does, according to NIMH.
- A Lancet network meta-analysis of 522 trials found all 21 antidepressants studied more effective than placebo, with modest differences between them, so side effects and fit usually drive the choice.
- Early dropout is common. In a national survey, 42.4% of adults starting an antidepressant for depression stopped within 30 days, and only 27.6% continued past 90 days.
- Staying on treatment after you improve lowers relapse risk. Across 31 trials, continuing an antidepressant cut the odds of relapse by 70%, with relapse rates of 18% on medication versus 41% on placebo.
- About 31% of people stopping an antidepressant report at least one discontinuation symptom, compared with 17% stopping placebo, so any plan to stop should be a gradual taper with your prescriber.
Starting an antidepressant can feel like a leap. You’ve heard they take weeks, that side effects can show up first, and that some people stop and feel worse. Before you commit, you want to know what you’re actually signing up for.
Here’s what’s happening underneath. Most antidepressants change how your brain recycles chemical messengers like serotonin, norepinephrine, or dopamine, and the benefit builds gradually as your brain adapts. NIMH’s medication guide notes that antidepressants usually take 4 to 8 weeks to work, and that sleep, appetite, energy, and concentration often improve before mood lifts. Getting through that window takes precision, because the hardest weeks come before the payoff.
The standard approach is well established. Antidepressants have been tested in hundreds of trials, and a Lancet meta-analysis of 522 trials and 116,477 people found all 21 antidepressants it studied more effective than placebo. For most people, the question isn’t whether antidepressants can work but which one fits. The results are real, and the science is well established.
But a prescription is only the first step, and at Siggy we’d rather plan for the weeks when most people quit than treat the first appointment as the finish line.
That follow-through is the part most care skips. In a national survey of 829 adults starting an antidepressant for depression, 42.4% stopped within the first 30 days and only 27.6% continued past 90 days. Staying on treatment long enough, then stopping carefully when the time comes, is where much of the benefit is won or lost. That conclusion comes from the trial data, and it shapes what a good plan looks like.
What This Page Covers
- How Do Antidepressants Work?
- What Are the Main Types of Antidepressants?
- How Well Do Antidepressants Work?
- How Do Prescribers Choose One?
- What Should You Expect in the First Weeks?
- Why Do So Many People Stop Too Soon?
- How Long Should You Stay on an Antidepressant?
- How Siggy Fits In
- The Bottom Line on Antidepressants
- Start Your Anonymous Intake
How Do Antidepressants Work?
Mayo Clinic’s antidepressant guide explains that most antidepressants work by affecting serotonin, norepinephrine, and dopamine, chemical messengers that help brain cells communicate, with each type acting in a slightly different way. After a nerve cell releases one of these messengers, a transporter pulls it back in to be reused. SSRIs slow that recycling for serotonin, and SNRIs slow it for serotonin and norepinephrine.
The chemical change happens quickly, but feeling better doesn’t. That gap is why NIMH describes a 4 to 8 week timeline and encourages giving a medication a real chance before deciding whether it’s right for you. Our guide on how long antidepressants take to work walks through that timeline week by week.
What Are the Main Types of Antidepressants?
NIMH explains that newer antidepressants are commonly prescribed because they cause fewer side effects than older ones and help a broad range of depressive and anxiety disorders, while older tricyclics and MAOIs cause more side effects but may be the best option for some people. The table below summarizes common trade-offs from NIMH and Mayo Clinic.
| Class | Examples | What to Know |
|---|---|---|
| SSRIs | Sertraline, escitalopram, fluoxetine | Often first; upset stomach, headache, sexual side effects |
| SNRIs | Venlafaxine, duloxetine, desvenlafaxine | Duloxetine also used for pain |
| Bupropion | Wellbutrin | Sexual side effects less common; may aid quitting smoking |
| Tricyclics | Nortriptyline, amitriptyline | More side effects, usually tried later |
| MAOIs | Phenelzine, tranylcypromine | Strict diet, serious drug interactions |
For every option in each class, see our complete antidepressant list.
How Well Do Antidepressants Work?
They work better than placebo, and the differences between them are smaller than marketing suggests. In the Lancet analysis, every antidepressant beat placebo for response, but differences between individual drugs were modest and most head-to-head comparisons had wide uncertainty. The authors also noted that effect sizes were smaller in newer, larger placebo-controlled trials.
Real-world numbers deserve an honest look too. The STAR*D study gave adults with depression up to four treatment steps, and the original report described a cumulative remission rate of 67%. A 2023 reanalysis using the study’s protocol-specified rating scale found a cumulative remission rate of 35.0%, about half the original figure.
What both readings share is that many people needed more than one try. If your first antidepressant doesn’t work, that’s common and doesn’t mean medication can’t help you.
How Do Prescribers Choose One?
Because the drugs perform similarly on average, the choice usually comes down to you. Mayo Clinic lists factors such as your specific symptoms, likely side effects, other health conditions, other medications, and how you or a close relative responded before. A medication that causes drowsiness might suit someone who can’t sleep, for example, and duloxetine may help when chronic pain is also part of the picture.
Bring your history to the conversation: what you’ve tried, at what dose, for how long, and why you stopped. Our guide to first-line vs. second-line antidepressants explains how that history shapes the next step.
What Should You Expect in the First Weeks?
Side effects often arrive before benefits. NIMH lists upset stomach, headache, and sexual dysfunction as common side effects of SSRIs and other antidepressants, and notes they’re generally mild and tend to fade with time. People who are sensitive to side effects sometimes do better starting at a low dose and increasing slowly.
NIMH also notes that children, teenagers, and young adults under 25 may have an increase in suicidal thoughts or behavior, especially in the first few weeks or after a dose change, and that people of all ages should be watched closely early in treatment. If you notice new or worsening thoughts of suicide, call or text 988, or call 911 in an emergency.
For a closer look at this stretch, our guide to the first 8 weeks on an antidepressant covers what’s normal and when to call your prescriber.
Why Do So Many People Stop Too Soon?
Early side effects, slow benefits, and too little follow-up add up. In the national survey above, stopping within the first 30 days was more common among people with lower incomes or less education. People who also received psychotherapy were more likely to continue past 30 days, 68.0% compared with 43.7%.
That pattern points to a fixable problem. When someone helps you anticipate the first few weeks, manage side effects, and recognize early improvement, you’re more likely to give the medication a fair trial.
How Long Should You Stay on an Antidepressant?
Longer than many people expect. MedlinePlus’s antidepressant overview notes that the typical length of treatment is 6 to 12 months, and some people stay on antidepressants much longer. In a Lancet review of 31 trials, continuing an antidepressant after responding cut the odds of relapse by 70%, with average relapse rates of 18% on medication and 41% on placebo.
The question is especially real when you feel better. In a NEJM trial published in 2021 with 478 primary care patients who felt well enough to consider stopping, 56% of those who tapered off relapsed within a year, compared with 39% who stayed on their medication.
How you stop matters as well. A 2024 meta-analysis of 79 studies found at least one discontinuation symptom in 31% of people stopping an antidepressant, compared with 17% stopping placebo, and estimated that about 1 in 6 to 7 people have symptoms caused by stopping. Severe symptoms were uncommon, at about 2.8%. Any plan to stop should be a gradual taper with your prescriber.
How Siggy Fits In
Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including depression and anxiety. The anonymous intake asks for no name, email, or account, so you can describe your symptoms, past medications, and the side effects that worry you in your own words.
If medication may help, a licensed prescriber reviews your full intake before anything is prescribed, and you get a downloadable summary you can keep or share with any clinician. The goal is a plan you can actually stay with.
Siggy isn’t an emergency service. If you’re in crisis or thinking about suicide, call 911 or call or text 988. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.
The Bottom Line on Antidepressants
Antidepressants work better than placebo, the main options perform similarly on average, and the right choice usually depends on your symptoms, side effects, and health history. The bigger risks are quitting in the first month, before the medication has a chance, and stopping abruptly once you feel better. If you’re weighing medication against therapy, our comparison of medication vs. therapy for depression lays out the evidence for each.
Start Your Anonymous Intake
If you’re thinking about starting an antidepressant, or you’re on one and unsure it’s working, a clear plan helps. Start your anonymous intake and describe what you’ve tried and what you’re hoping changes. It’s free, there’s no name or email required, and a licensed prescriber reviews every clinical decision. Your summary is yours to share with whoever helps you next.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
How do antidepressants work?
Most antidepressants work by affecting chemical messengers such as serotonin, norepinephrine, and dopamine, with each type acting in a slightly different way. SSRIs slow the recycling of serotonin, and SNRIs slow it for serotonin and norepinephrine. The benefit builds gradually, which is why NIMH notes antidepressants usually take 4 to 8 weeks to work.
How long do antidepressants take to work?
Antidepressants usually take 4 to 8 weeks to work, according to NIMH. Problems with sleep, appetite, energy, and concentration often improve before mood lifts, so early changes in those areas can be a sign the medication is starting to help.
Which antidepressant is the best?
No single antidepressant is best for everyone. A 2018 Lancet network meta-analysis of 522 trials found all 21 antidepressants it studied more effective than placebo, with modest differences between them. Prescribers usually choose based on your symptoms, side-effect concerns, other health conditions, other medications, and how you've responded before.
What happens if you stop an antidepressant suddenly?
Stopping suddenly can cause discontinuation symptoms and raises the risk of relapse. A 2024 meta-analysis found at least one discontinuation symptom in 31% of people stopping an antidepressant versus 17% stopping placebo. In a 2021 NEJM trial, 56% of people who tapered off relapsed within a year, compared with 39% who stayed on their medication.
How long do you need to stay on an antidepressant?
MedlinePlus notes that the typical length of treatment is 6 to 12 months, and some people stay on antidepressants much longer. A Lancet review of 31 trials found that continuing an antidepressant after responding cut the odds of relapse by 70%, so the decision to stop is best made with your prescriber.
Are antidepressants safe for young adults?
Antidepressants are widely used, but NIMH notes that children, teenagers, and young adults under 25 may have an increase in suicidal thoughts or behavior, especially in the first few weeks or after a dose change. People of all ages should be watched closely early in treatment. If you have thoughts of suicide, call or text 988.
Sources
- National Institute of Mental Health. Mental Health Medications. nimh.nih.gov
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-1366. doi:10.1016/S0140-6736(17)32802-7
- Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. American Journal of Psychiatry. 2006;163(1):101-108. doi:10.1176/appi.ajp.163.1.101
- Mayo Clinic. Antidepressants: Selecting one that’s right for you. mayoclinic.org
- Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry. 2006;163(11):1905-1917. doi:10.1176/ajp.2006.163.11.1905
- Pigott HE, Kim T, Xu C, et al. What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study’s patient-level data with fidelity to the original research protocol. BMJ Open. 2023;13(7):e063095. doi:10.1136/bmjopen-2022-063095
- MedlinePlus. Antidepressants. National Library of Medicine. medlineplus.gov
- Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003;361(9358):653-661. doi:10.1016/S0140-6736(03)12599-8
- Lewis G, Marston L, Duffy L, et al. Maintenance or discontinuation of antidepressants in primary care. New England Journal of Medicine. 2021;385(14):1257-1267. doi:10.1056/NEJMoa2106356
- Henssler J, Schmidt Y, Schmidt U, et al. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. Lancet Psychiatry. 2024;11(7):526-535. doi:10.1016/S2215-0366(24)00133-0